We are live on
!
Find out more
Pacer Advisors Portfolio holdings
AUM
$35.6B
1-Year Est. Return
18.19%
This Fund
S&P 500
This Quarter
Est. Return
+10.34%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$5.32B
AUM Growth
+$623M
(+13%)
Cap. Flow
+$473M
Cap. Flow
% of AUM
8.88%
Top 10 Holdings %
Top 10 Hldgs %
31.02%
Holding
1,563
New
308
Increased
332
Reduced
859
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equinix
EQIX
|
+$43.7M |
| 2 |
American Tower
AMT
|
+$34.7M |
| 3 |
Crown Castle
CCI
|
+$21.3M |
| 4 |
CD
Chindata Group Holdings Limited American Depositary Shares
CD
|
+$19.1M |
| 5 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$13.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$80.9M |
| 2 |
Microsoft
MSFT
|
+$63.9M |
| 3 |
Amazon
AMZN
|
+$61.8M |
| 4 |
Meta Platforms (Facebook)
META
|
+$26.4M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$24.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 18.33% |
| 2 | Technology | 16.44% |
| 3 | Consumer Discretionary | 8.8% |
| 4 | Healthcare | 7.69% |
| 5 | Communication Services | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Wheaton Precious Metals
WPM
$49.6B
| $147K | ﹤0.01% |
+3,510
| New | +$157K |
|
1152
BioMarin Pharmaceuticals
BMRN
$11.9B
| $146K | ﹤0.01% |
1,665
-11,832
| -88% | -$938K |
|
|
ARNA
1153
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $146K | ﹤0.01% |
1,906
+192
| +11% | +$14.4K |
|
1154
Dropbox
DBX
$7.73B
| $144K | ﹤0.01% |
6,498
+576
| +10% | +$11.7K |
|
1155
Agnico Eagle Mines
AEM
$71.8B
| $142K | ﹤0.01% |
+2,011
| New | +$150K |
|
1156
BioXcel Therapeutics
BTAI
$25M
| $142K | ﹤0.01% |
192
+96
| +100% | +$74.8K |
|
1157
Sarepta Therapeutics
SRPT
$1.65B
| $141K | ﹤0.01% |
829
+168
| +25% | +$24.9K |
|
|
GBT
1158
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $141K | ﹤0.01% |
3,250
+1,574
| +94% | +$77.6K |
|
1159
Tenaris
TS
$28.2B
| $140K | ﹤0.01% |
+8,794
| New | +$117K |
|
|
CCXI
1160
DELISTED
ChemoCentryx, Inc.
CCXI
| $140K | ﹤0.01% |
2,259
+644
| +40% | +$36.9K |
|
1161
CareDx
CDNA
$1.84B
| $139K | ﹤0.01% |
1,912
-582
| -23% | -$33.7K |
|
1162
Denali Therapeutics
DNLI
$3.78B
| $139K | ﹤0.01% |
1,656
-214
| -11% | -$12.9K |
|
1163
Macerich
MAC
$7.52B
| $139K | ﹤0.01% |
12,982
-15,109
| -54% | -$137K |
|
1164
Neurocrine Biosciences
NBIX
$18.3B
| $139K | ﹤0.01% |
1,455
+542
| +59% | +$52.4K |
|
1165
Acadia Pharmaceuticals
ACAD
$4.49B
| $138K | ﹤0.01% |
2,584
+294
| +13% | +$14.6K |
|
|
FOLD
1166
DELISTED
Amicus Therapeutics
FOLD
| $138K | ﹤0.01% |
5,986
-3,632
| -38% | -$74.3K |
|
1167
Greif
GEF
$4.83B
| $138K | ﹤0.01% |
2,939
-3,423
| -54% | -$155K |
|
1168
Vera Bradley
VRA
$100M
| $138K | ﹤0.01% |
+17,298
| New | +$131K |
|
1169
Natera
NTRA
$35.9B
| $136K | ﹤0.01% |
1,362
-1,204
| -47% | -$101K |
|
1170
News Corp Class B
NWS
$17.7B
| $136K | ﹤0.01% |
7,678
-901
| -11% | -$14.5K |
|
1171
Rogers Communications
RCI
$19B
| $136K | ﹤0.01% |
+2,921
| New | +$129K |
|
|
XLRN
1172
DELISTED
Acceleron Pharma
XLRN
| $136K | ﹤0.01% |
1,060
-44
| -4% | -$5.16K |
|
|
EXAS
1173
DELISTED
Exact Sciences
EXAS
| $135K | ﹤0.01% |
1,019
-210
| -17% | -$25.4K |
|
|
TPTX
1174
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $135K | ﹤0.01% |
1,111
| – | – |
|
|
BLUE
1175
DELISTED
bluebird bio
BLUE
| $134K | ﹤0.01% |
240
+113
| +89% | +$71.6K |
|
Similar funds
SAM
Pacer Advisors's Q4 2020 Portfolio in Review
As of Q4 2020, Pacer Advisors held 1,563 positions worth $5.32B, up 13% from $4.7B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Pacer Advisors deployed $473M of net new capital in Q4 2020, opening 308 new positions and adding to 332 existing holdings. Its largest new stake was Chindata Group Holdings Limited American Depositary Shares: 1,166,530 shares worth $27.9M.
By sector, the portfolio is most concentrated in Real Estate at 18% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $80.9M trimmed.
- Pacer Advisors's largest Q4 2020 buy was Chindata Group Holdings Limited American Depositary Shares: 1,166,530 shares worth $27.9M.
- Pacer Advisors added most to Equinix in Q4 2020, an estimated $43.7M increase.
- Pacer Advisors's biggest Q4 2020 reduction was Apple, cutting an estimated $80.9M.
- Pacer Advisors fully exited INDUS Realty Trust, Inc. (MD) Common Stock in Q4 2020, selling an estimated $1.83M.
- Pacer Advisors's ten largest holdings make up 31% of its $5.32B portfolio in Q4 2020.
- Pacer Advisors opened 308 new positions and closed 60 in Q4 2020.
- Pacer Advisors's portfolio value rose 13% quarter-over-quarter to $5.32B.
Based on Pacer Advisors's 13F filing for Q4 2020, filed 20 Jan 2021.